The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1R,3R)-3-(4-(1H-indol-3-yl)-1H-imidazol-2-yl)-1-(tetrahydro-2H-pyran-4-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole ID: ALA3775643
PubChem CID: 127032663
Max Phase: Preclinical
Molecular Formula: C27H27N5O
Molecular Weight: 437.55
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc2c(-c3c[nH]c([C@H]4Cc5c([nH]c6ccccc56)[C@@H](C5CCOCC5)N4)n3)c[nH]c2c1
Standard InChI: InChI=1S/C27H27N5O/c1-3-7-21-18(6-1)20(14-28-21)24-15-29-27(32-24)23-13-19-17-5-2-4-8-22(17)30-26(19)25(31-23)16-9-11-33-12-10-16/h1-8,14-16,23,25,28,30-31H,9-13H2,(H,29,32)/t23-,25-/m1/s1
Standard InChI Key: UAAOHFNDGBMJOG-ILBGXUMGSA-N
Molfile:
RDKit 2D
33 39 0 0 0 0 0 0 0 0999 V2000
-3.7006 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7006 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4915 -1.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4915 1.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2274 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2274 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.3190 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2274 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2274 -0.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4732 -1.3190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7372 -0.6045 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7372 0.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4732 1.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0335 1.5807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1716 3.0613 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6389 3.3729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3886 2.0737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3847 0.9592 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4684 -2.8198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7672 -3.5709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7663 -5.0709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4668 -5.8201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1682 -5.0693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1691 -3.5693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8811 1.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5054 0.5633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9654 0.7602 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9396 2.9455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2501 2.2261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5443 2.9924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5046 4.5116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1941 5.2310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8912 4.4487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 9 1 0
8 5 1 0
8 9 2 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 2 0
12 14 1 6
19 20 1 0
19 24 1 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
10 19 1 6
25 26 2 0
26 27 1 0
27 29 1 0
28 25 1 0
17 25 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 437.55Molecular Weight (Monoisotopic): 437.2216AlogP: 5.39#Rotatable Bonds: 3Polar Surface Area: 81.52Molecular Species: NEUTRALHBA: 3HBD: 4#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.46CX Basic pKa: 7.48CX LogP: 4.09CX LogD: 3.75Aromatic Rings: 5Heavy Atoms: 33QED Weighted: 0.31Np Likeness Score: 0.08
References 1. He S, Dobbelaar PH, Guo L, Ye Z, Liu J, Jian T, Truong Q, Shah SK, Du W, Qi H, Bakshi RK, Hong Q, Dellureficio JD, Sherer E, Pasternak A, Feng Z, Reibarkh M, Lin M, Samuel K, Reddy VB, Mitelman S, Tong SX, Chicchi GG, Tsao KL, Trusca D, Wu M, Shao Q, Trujillo ME, Fernandez G, Nelson D, Bunting P, Kerr J, Fitzgerald P, Morissette P, Volksdorf S, Eiermann GJ, Li C, Zhang BB, Howard AD, Zhou YP, Nargund RP, Hagmann WK.. (2016) SAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonists., 26 (6): [PMID:26898814 ] [10.1016/j.bmcl.2016.02.022 ]